|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | International Autoimmune Hepatitis Group Report: review of criteria for diagnosis of autoimmune hepatitis显示文摘 | F. Alvarez P.A. Berg F.B. Bianchi L. Bianchi A.K. Burroughs E.L. Cancado R.W. Chapman W.G.E. Cooksley A.J. Czaja V.J. Desmet P.T. Donaldson A.L.W.F. Eddleston L. Fainboim J. Heathcote J.-C. Homberg J.H. Hoofnagle S. Kakumu E.L. Krawitt I.R. Mackay R.N.M. | 1999 | Journal of Hepatology1999，，5： | 4 |
| 2 | International Autoimmune Hepatitis Group Report: review of criteria for diagnosis of autoimmune hepatitis显示文摘 | F. Alvarez P.A. Berg F.B. Bianchi L. Bianchi A.K. Burroughs E.L. Cancado R.W. Chapman W.G.E. Cooksley A.J. Czaja V.J. Desmet P.T. Donaldson A.L.W.F. Eddleston L. Fainboim J. Heathcote J.-C. Homberg J.H. Hoofnagle S. Kakumu E.L. Krawitt I.R. Mackay R.N.M. | 1999 | Journal of Hepatology1999，，5： | 2 |
| 3 | Relapse rates in chronic hepatitis B na?ve patients after discontinuation of antiviral therapy with entecavir显示文摘 | E. Ridruejo S. Marciano O. Galdame M. V. Reggiardo A. E. Mu?oz R. Adrover D. Cocozzella N. Fernandez C. Estepo M. Mendizábal G. A. Romero D. Levi T. Schroder S. Paz H. Fainboim O. G. Mandó A. C. Gadano M. O. Silva | 2014 | J Viral Hepat2014，，8： | 1 |
| 4 | Boceprevir versus placebo with pegylated interferon alfa-2b and ribavirin for treatment of hepatitis C virus genotype 1 in patients with HIV: a randomised, double-blind, controlled phase 2 trial显示文摘 | Mark Sulkowski Stanislas Pol Josep Mallolas Hugo Fainboim Curtis Cooper Jihad Slim Antonio Rivero Carmen Mak Seth Thompson Anita YM Howe Larissa Wenning Peter Sklar Janice Wahl Wayne Greaves | 2013 | The Lancet Infectious Diseases2013，，7： | 1 |
| 5 | Up-regulated expression of MICA on activated T lymphocytes involves Lck and Fynkinases and signaling through MEK1 /ERK, p38 MAP kinase, and calcineurin 显示文摘 | Molinero L L Fuertes M B Fainboim L | 2003 | J Leukoc Biol2003，73，6： | 1 |
| 6 | Hepatitis B virus in peripheral blood mononuclear cells during the course of viral infection显示文摘 | Roisman FR Castello A Fainboim H | 1994 | Clin Immunol Immunopathol1994，70，2： | 1 |
| 7 | Hepatitis B virus in Buenos Aires, Argentina: genotypes, virological characteristics and clinical outcomes 显示文摘 | PEZZANO SC TORRES C FAINBOIM HA | 2011 | Clin Microbiol Infect2011，17，2： | 1 |
| 8 | Cytokines and chronic liver disease 显示文摘 | Fainboim L Chernavsky A Paladino N | 2007 | Cytokine Growth Factor Rev2007，18，12： | 1 |
| 9 | Gender susceptibility to chronic hepatitis C virus infection associated with interleukin 10 promoter polymorphism显示文摘 | Paladino N Fainboim H Theiler G | | 0，，18： | 1 |
| 10 | NF-kappa B regulates expression of the MHC class I-related chain A gene in activated T lymphocyes 显示文摘 | Molinero LL Fuertes MB Girart MV Fainboim L Rabinovich GA Costas MA | 2004 | J Immunol2004，173，9： | 1 |
| 11 | Up-regulated expression of MICA on activated T lymphocytes involves Lck and Fyn kinases and signaling through MEK1/ERK,p38 MAP kinase, and calcineurin显示文摘 | Moliero LL Fuertes MB Fainboim L | 2003 | Molinero J Leukoc Biol2003，73，6： | 1 |
| 12 | Targeted inhibition of galectin-1 gene expression in tumor cells results in heightened T cell-mediated rejection显示文摘 | Natalia Rubinstein Mariano Alvarez Norberto W Zwirner Marta A Toscano Juan M Ilarregui Alicia Bravo José Mordoh Leonardo Fainboim Osvaldo L Podhajcer Gabriel A Rabinovich | 2004 | Cancer Cell2004，，3： | 1 |
| 13 | International auto immune hepatitis group report:review of criteria for diagnosis of autoimmune hepatitis显示文摘 | Fainboim L Heathcote J Homberg JC | 1999 | J Hepatol1999，51，5： | 1 |
| 14 | Hepatitis B virus in Buenos Aires,Argentina:genotypes,virological characteristics and clinical outcomes显示文摘 | Pezzano SC Torres C Fainboim HA | 2011 | Clin Microbiol Infect2011，17，： | 1 |
| 15 | Hepatitis B virus in peripheral blood mononuclear cells during the course of viral infection 显示文摘 | Roisman FR Castello A Fainboim H | 1994 | Clin Immunol Immunopathol1994，70，2： | 1 |
| 16 | Gender susceptibility to chronic hepatitis C virus infection associated with interleukin 10 promoter polymorphism显示文摘 | Paladino N Fainboim H Theiler G | 2006 | J Virol2006，80，18： | 1 |
| 17 | Unlocking the secrets of galectins:a challenge at the frontier of glyco -immunology显示文摘 | Rabinovich GA Rubinstein N Fainboim L | 2002 | J Leukoc Biol2002，71，5： | 1 |
| 18 | Pre-treatment prediction of response to peginterferon plus ribavirin in chronic hepatitis C genotype 3显示文摘AIM: To evaluate pre-treatment factors associated with sustained virological response(SVR) in patients with hepatitis C virus(HCV) genotype 3 treated with peginterferon and ribavirin(RBV). METHODS: We retrospectively analyzed treatment naive, mono-infected HCV genotype 3 patients treated with peginterferon and RBV. Exclusion criteria included presence of other liver disease, alcohol consumption and African American or Asian ethnicity. The variables collected and compared between patients who achieved an SVR and patients who did not were as follows: gender, age, fibrosis stage, diabetes, body mass index,steatosis, INFL3 polymorphism, pre-treatment HCVRNA, type of peginterferon, RBV dose and adherence. RESULTS: A total of 107 patients treated between June, 2004 and March, 2013 were included. Mean treatment duration was 25.1(± 1.8) wk. Overall, 58%(62/107) of the patients achieved an SVR and 42%(45/107) did not. In the multivariate logistic regression analysis, pre-treatment HCV-RNA ≥ 600000 UI/m L(OR = 0.375, 95%CI: 0.153-0.919, P = 0.032) and advanced fibrosis(OR = 0.278, 95%CI: 0.113-0.684,P = 0.005) were significantly associated with low SVR rates. In patients with pre-treatment HCV-RNA ≥600000 UI/m L and advanced fibrosis, the probability of achieving an SVR was 29%(95%CI: 13.1-45.2).In patients with pre-treatment HCV-RNA < 600000UI/m L and mild to moderate fibrosis, the probability of achieving an SVR was 81%(95%CI: 68.8-93.4).CONCLUSION: In patients with HCV genotype 3infections the presence of advance fibrosis and high pre-treatment viral load might be associated with poor response to peginterferon plus RBV. These patients could benefit the most from new direct antiviral agentsbased regimes. | Sebastian Marciano Silvia M Borzi Melisa Dirchwolf Ezequiel Ridruejo Manuel Mendizabal Fernando Bessone Maria E Sirotinsky Diego H Giunta Julieta Trinks Pablo A Olivera Omar A Galdame Marcelo O Silva Hugo A Fainboim Adrian C Gadano | 2015 | World Journal of Hepatology2015，7，4： | 1 |
| 19 | HLA Haplotypes and Class II Molecular Alleles in Argentinian Patients with Pemphigus Vulgaris显示文摘 | Roberto Glorio Graciela Rodriguez Costa Roxana Haas Mijail Gruber Leonardo Fainboim Alberto Woscoff | 2002 | Journal of Cutaneous Medicine and Surgery: Incorporating Medical and Surgical Dermatology2002，，5： | 1 |
| 20 | Hepatitis B virus in peripheral blood mononuclear cells during the course of viral infection显示文摘 | Roisman FR Castello A Fainboim H | 1994 | Clin Immunol Immunopathol1994，70，2： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员